Using clinical data from HCC patients in TCGA, which included clinical stage, tumor grade, survival status, age, gender, and pathological tumor-node-metastasis (pTNM) stage, the association between SGOL1 expression level and the clinical and pathological characteristics of HCC patients was evaluated. This evidence concerns the gene SGO1 and hepatocellular carcinoma.